CD133 antigen expression in ovarian cancer (Q21093306)

neoplastic gene expression regulation

1 reference

1 reference

1 reference

7

Giovanni Scambia

Giovanni

Scambia

1 reference

14 July 2022

1

Gabriella Ferrandina

Gabriella

Ferrandina

1 reference

14 July 2022

4

Maria Grazia Prisco

Maria Grazia

Prisco

1 reference

14 July 2022

Marco Petrillo

Marco

Petrillo

3

1 reference

14 July 2022

Enrica Martinelli

2

Enrica

Martinelli

1 reference

14 July 2022

Gianfranco Zannoni

series ordinal

5

author given names

Gianfranco

author last names

Zannoni

1 reference

14 July 2022

Stefano Sioletic

series ordinal

6

author given names

Stefano

author last names

Sioletic

1 reference

14 July 2022

language of work or name

English

0 references

publication date

2009

0 references

published in

BMC Cancer

0 references

volume

9

0 references

issue

1

0 references

page(s)

221

0 references

copyright license

Creative Commons Attribution 2.0 Generic

start time

7 July 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2407-9-221

0 references

cites work

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Prospective identification of tumorigenic breast cancer cells

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Identification and expansion of human colon-cancer-initiating cells

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Identification of human brain tumour initiating cells

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Exploring the role of cancer stem cells in radioresistance

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

CD133: molecule of the moment

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Nonparametric Estimation from Incomplete Observations

19 March 2017

1 reference

https://api.crossref.org/works/10.1186/1471-2407-9-221

Prospective identification of tumorigenic prostate cancer stem cells

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Identification of bronchioalveolar stem cells in normal lung and lung cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Targeting CD133 antigen in cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Pluripotent human stem cell lines: what we can learn about cancer initiation.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Evaluation of survival data and two new rank order statistics arising in its consideration

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224735

Increased expression of stem cell markers in malignant melanoma.

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-221

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-221

Expression of CD133-1 and CD133-2 in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-221

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-221

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer

21 January 2018

1 reference

12 December 2020

Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases

1 reference

12 December 2020

Tumor growth need not be driven by rare cancer stem cells

2 references

12 December 2020

https://api.crossref.org/works/10.1186%2F1471-2407-9-221

7 January 2021

inferred from DOI database lookup

Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence

1 reference

12 December 2020

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

1 reference

12 December 2020